EDIT vs LDOS · rev $32.3M vs P/E 16, rev $16.66B
Editas Medicine Inc (EDIT) versus Leidos Holdings Inc (LDOS) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported LDOS revenue for 2025-01-03 was $16.66B. Net income was $1.25B. Revenue was up 7.9% from 2023-12-29 to 2025-01-03. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
EDIT currently screens at market cap $375.2M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Not investment advice. Open the EDIT and LDOS stock pages for the full models.
Not investment advice.